You are here

  • Home
  • Archive
  • Volume 6, Issue 3
  • Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib

Article metrics

Article menu

Download PDFPDF

XML
Rheumatoid arthritis
Original research
Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib

 

Online download statistics by month:

Online download statistics by month: October 2020 to March 2024

AbstractFullPdf
Oct 2020399394193
Nov 202020020059
Dec 202020219685
Jan 202111811043
Feb 202111010141
Mar 202112912851
Apr 20211009734
May 202113313044
Jun 202110210133
Jul 2021979737
Aug 2021929129
Sep 202119418565
Oct 202114113646
Nov 2021807240
Dec 202111711326
Jan 2022757316
Feb 202211311032
Mar 202212912650
Apr 202211010419
May 202211010736
Jun 202212012532
Jul 202210910944
Aug 202212712833
Sep 202210710632
Oct 202213312616
Nov 202212412231
Dec 2022686819
Jan 202311010723
Feb 2023949211
Mar 2023939029
Apr 2023767521
May 2023747119
Jun 2023939225
Jul 2023494713
Aug 2023999622
Sep 2023808019
Oct 202311411117
Nov 2023818014
Dec 2023888313
Jan 2024854414
Feb 202412811425
Mar 202411711737
Total492047541488